Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9251-9300 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04902417
Dairy and Inflammation Study
NAActive, not recruiting
32 participants
Started: May 1, 2022 · Completed: Dec 30, 2024
3 conditions2 sponsors1 location
NCT05860140
Preventing Malnutrition Among Older Adults
NAActive, not recruiting
250 participants
Started: May 1, 2022 · Completed: Jun 6, 2026
1 condition1 sponsor1 location
NCT04702542
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
NAActive, not recruiting
320 participants
Started: Apr 30, 2022 · Completed: Dec 30, 2028
4 conditions1 sponsor1 location
NCT06189053
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
N/AActive, not recruiting
1,500 participants
Started: Apr 30, 2022 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT05446714
Evaluation of the Effect of Three Types of Rapid Maxillary Expanders (Conventional, Hybrid and MSE)
NAActive, not recruiting
54 participants
Started: Apr 30, 2022 · Completed: Jun 20, 2025
2 conditions2 sponsors1 location
NCT05360719
Integrated Tele-exercise for Individuals With Spinal Cord Injury
NAActive, not recruiting
35 participants
Started: Apr 30, 2022 · Completed: May 30, 2026
1 condition3 sponsors1 location
NCT05240534
ElderTree Via a Voice Activated Device for Managing Chronic Health Conditions (NHLBI)
NAActive, not recruiting
502 participants
Started: Apr 29, 2022 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT04964362
The Impact of Injustice Appraisals on Psychosocial Outcomes Following Spinal Cord Injury: A Longitudinal Study
N/AActive, not recruiting
113 participants
Started: Apr 29, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05231707
Simunye: A Couples-focused Intervention for HIV Prevention and Care in South Africa
NAActive, not recruiting
544 participants
Started: Apr 29, 2022 · Completed: May 1, 2026
1 condition3 sponsors1 location
NCT05227170
Impact of Lp299v on Vascular Function in Patients With PASC
NAActive, not recruiting
80 participants
Started: Apr 29, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05356637
Bipolar Sealer for Reduction of Blood Loss in Anterior Total Hip Arthroplasties
NAActive, not recruiting
75 participants
Started: Apr 29, 2022 · Completed: Feb 1, 2024
2 conditions2 sponsors2 locations
NCT05444894
EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)
PHASE1/PHASE2Active, not recruiting
9 participants
Started: Apr 29, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor8 locations
NCT05162768
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)
PHASE3Active, not recruiting
102 participants
Started: Apr 29, 2022 · Completed: Oct 31, 2024
8 conditions1 sponsor32 locations
NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC
PHASE2Active, not recruiting
93 participants
Started: Apr 29, 2022 · Completed: Dec 31, 2024
7 conditions5 sponsors8 locations
NCT06295939
Effect of Social Support Program on Grief of Pregnancy Loss in Sunpasitthiprasong Hospital
NAActive, not recruiting
90 participants
Started: Apr 29, 2022 · Completed: May 31, 2024
3 conditions1 sponsor1 location
NCT05255900
Effects of Metyrapone in Patients With Hypercortisolism
N/AActive, not recruiting
20 participants
Started: Apr 28, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05353829
Methotrexate in Patients with Early Rheumatoid Arthritis
PHASE4Active, not recruiting
212 participants
Started: Apr 28, 2022 · Completed: Dec 31, 2026
1 condition12 sponsors13 locations
NCT05374174
Validation of a Spasticity Measurement Tool
N/AActive, not recruiting
40 participants
Started: Apr 28, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT07147361
Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma
N/AActive, not recruiting
800 participants
Started: Apr 28, 2022 · Completed: Jul 31, 2027
4 conditions1 sponsor1 location
NCT05312385
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)
PHASE3Active, not recruiting
235 participants
Started: Apr 28, 2022 · Completed: Oct 30, 2024
1 condition1 sponsor14 locations
NCT05395741
Regorafenib in Patients With Refractory Primary Bone Tumors
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Apr 28, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05148546
Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
PHASE2Active, not recruiting
69 participants
Started: Apr 28, 2022 · Completed: Apr 30, 2029
1 condition2 sponsors2 locations
NCT05328934
SoftHand Comparison Study
NAActive, not recruiting
36 participants
Started: Apr 28, 2022 · Completed: May 31, 2026
4 conditions3 sponsors2 locations
NCT04320342
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD
PHASE3Active, not recruiting
3,433 participants
Started: Apr 28, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor436 locations
NCT06318494
Analysis of Jumping in Patients With Ankle Instability (Ankle-optogait)
NAActive, not recruiting
50 participants
Started: Apr 28, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06639100
This Will Be an Observational, Exploratory Study Targeting a Population of Subjects with Diabetes from 4 Different Geographical Areas of Emilia- Romagna.
N/AActive, not recruiting
63,500 participants
Started: Apr 27, 2022 · Completed: Oct 26, 2024
1 condition1 sponsor1 location
NCT06457399
Heliox on the Work of Breathing in Adult Patients With Lower Airway Stenosis
N/AActive, not recruiting
18 participants
Started: Apr 27, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05035823
COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis
NAActive, not recruiting
6 participants
Started: Apr 27, 2022 · Completed: Sep 30, 2026
12 conditions1 sponsor3 locations
NCT05192616
Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease
N/AActive, not recruiting
241 participants
Started: Apr 27, 2022 · Completed: Jun 30, 2026
5 conditions1 sponsor18 locations
NCT04403139
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
PHASE4Active, not recruiting
50 participants
Started: Apr 27, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05149755
Evolut™ EXPAND TAVR II Pivotal Trial
NAActive, not recruiting
650 participants
Started: Apr 27, 2022 · Completed: Dec 31, 2034
1 condition1 sponsor97 locations
NCT05003609
Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation
NAActive, not recruiting
100 participants
Started: Apr 27, 2022 · Completed: May 30, 2025
1 condition3 sponsors7 locations
NCT05265039
Exploring Mechanisms of Massed Cognitive Processing Therapy
NAActive, not recruiting
140 participants
Started: Apr 26, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05256537
Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil
PHASE2Active, not recruiting
60 participants
Started: Apr 26, 2022 · Completed: Mar 7, 2026
1 condition1 sponsor1 location
NCT05735210
Polso™ Watch Blood Pressure Accuracy With Blood Pressure Change Validation
NAActive, not recruiting
185 participants
Started: Apr 26, 2022 · Completed: Jul 1, 2024
1 condition2 sponsors1 location
NCT05311631
Breastfeeding - a Good Start Together
NAActive, not recruiting
5,010 participants
Started: Apr 26, 2022 · Completed: Dec 31, 2025
2 conditions5 sponsors21 locations
NCT05360056
Continuous Glucose Monitoring Following Hospital Discharge
NAActive, not recruiting
100 participants
Started: Apr 26, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05354557
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
PHASE2Active, not recruiting
16 participants
Started: Apr 26, 2022 · Completed: Apr 26, 2026
1 condition1 sponsor8 locations
NCT05323175
Erector Spinae Plane (ESP) Block for Renal Colic
PHASE4Active, not recruiting
24 participants
Started: Apr 25, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05332769
Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality (FLIM)
N/AActive, not recruiting
200 participants
Started: Apr 25, 2022 · Completed: Dec 30, 2026
4 conditions4 sponsors1 location
NCT05263310
Prepare for Your Diabetes Care
NAActive, not recruiting
600 participants
Started: Apr 25, 2022 · Completed: Mar 30, 2026
3 conditions2 sponsors1 location
NCT05289739
Exercise Training in Childhood Cancer
NAActive, not recruiting
450 participants
Started: Apr 25, 2022 · Completed: Aug 31, 2026
1 condition11 sponsors1 location
NCT05358717
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
PHASE2Active, not recruiting
252 participants
Started: Apr 25, 2022 · Completed: Aug 15, 2025
1 condition1 sponsor28 locations
NCT05057858
The Women TDF-FTC Benchmark Study
PHASE2Active, not recruiting
72 participants
Started: Apr 25, 2022 · Completed: Jan 31, 2025
1 condition4 sponsors1 location
NCT06036342
Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination
N/AActive, not recruiting
3,000 participants
Started: Apr 25, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05335590
Adherence and Clinical Correlates in Persons With HIV on TAF
N/AActive, not recruiting
384 participants
Started: Apr 25, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05171647
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
PHASE3Active, not recruiting
242 participants
Started: Apr 25, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor52 locations
NCT05330442
Building Experience for Treating Trauma and Enhancing Resilience (BETTER)
NAActive, not recruiting
720 participants
Started: Apr 25, 2022 · Completed: Jun 30, 2026
1 condition3 sponsors10 locations
NCT05346224
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
PHASE3Active, not recruiting
900 participants
Started: Apr 25, 2022 · Completed: Dec 30, 2025
3 conditions1 sponsor79 locations
NCT05331378
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression
NAActive, not recruiting
80 participants
Started: Apr 25, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location